Post by
doysen on Jan 01, 2020 9:30am
Rvv
Rvv trades for a fraction on tbp
market cap with fda orphan status on autoimmune hepatitis
rvv so undervalued
Comment by
1mattman on Jan 01, 2020 2:17pm
We heard you before Doysen. I even bought some shares but I’m not sure why you are making such an effort on the TBP board. Apples to oranges for sure. Do some more reading and I’m sure you’ll figure it out. Try PREV as well. RVV and PREV are much behind TBP with much less money invested.
Comment by
Stockthoughts on Jan 01, 2020 5:36pm
The company has no cash, no partner. Just starting out, way way behind TBP and other Pharma. It's great for bump and dump stocks
Comment by
weedopportunity on Jan 02, 2020 9:09am
He does the same thing on facebook with a the name of D lorne lambert he does the same thing on facebook with a the name of lorne lambert
Comment by
doysen on Jan 02, 2020 9:14am
yes agreed but it trades for 5 pct of tbp cap and 12 pct of inmed so serious disconnect tbp will burn through their last raise real quick too